Skip to main content

Closed

LRMR: Larimar Therapeutics, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

30thpctl

Volume

0.45×avg

Market Cap

396.83MUSD

P/E Ratio

-1.8TTM

Div Yield

-ann

Larimar Therapeutics, Inc.

LRMRNASDAQ Global Market·USD·Closed

Larimar Therapeutics, Inc.

LRMRNASDAQ·USD·Closed

$3.82

−0.13%

$3.82

−$0.01 (0.13%)

52W Range

30thpctl

Volume

0.45×avg

Mkt Cap

396.83MUSD

P/E

-1.8TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings